Common Stock, Shares, Outstanding of Applied Therapeutics, Inc. from 31 Dec 2018 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Applied Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2018 to 30 Sep 2025.
  • Applied Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 144,300,674, a 24% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Applied Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 144,300,674 +27,944,200 +24% 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 141,938,335 +27,092,064 +24% 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 141,575,526 +27,333,723 +24% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 137,228,741 +52,358,909 +62% 31 Dec 2024 10-Q 13 Nov 2025 2025 Q3
Q3 2024 116,356,474 +39,222,958 +51% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 114,846,271 +52,726,805 +85% 30 Jun 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 114,241,803 +66,128,242 +137% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 84,869,832 +36,806,474 +77% 31 Dec 2023 10-K 15 Apr 2025 2024 FY
Q3 2023 77,133,516 +29,074,560 +60% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 62,119,466 +15,865,942 +34% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 48,113,561 +21,898,047 +84% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 48,063,358 +21,847,844 +83% 31 Dec 2022 10-K 06 Mar 2024 2023 FY
Q3 2022 48,058,956 +21,844,557 +83% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 46,253,524 +20,122,988 +77% 30 Jun 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 26,215,514 +205,049 +0.79% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 26,215,514 +3,721,853 +17% 31 Dec 2021 10-K 23 Mar 2023 2022 FY
Q3 2021 26,214,399 +3,757,713 +17% 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 26,130,536 +3,799,394 +17% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 26,010,465 +4,041,188 +18% 31 Mar 2021 10-Q 11 May 2021 2021 Q1
Q4 2020 22,493,661 +3,962,101 +21% 31 Dec 2020 10-K 10 Mar 2022 2021 FY
Q3 2020 22,456,686 +5,322,496 +31% 30 Sep 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 22,331,142 +5,278,940 +31% 30 Jun 2020 10-Q 11 Aug 2020 2020 Q2
Q1 2020 21,969,277 +16,455,746 +298% 31 Mar 2020 10-Q 11 May 2020 2020 Q1
Q4 2019 18,531,560 +13,018,029 +236% 31 Dec 2019 10-K 18 Mar 2021 2020 FY
Q3 2019 17,134,190 30 Sep 2019 10-Q 13 Nov 2019 2019 Q3
Q2 2019 17,052,202 30 Jun 2019 10-Q 12 Aug 2019 2019 Q2
Q1 2019 5,513,531 31 Mar 2019 10-Q 21 Jun 2019 2019 Q1
Q4 2018 5,513,531 31 Dec 2018 10-K 13 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.